Á lódáil...
A PD-L2-based immune marker signature helps to predict survival in resected pancreatic ductal adenocarcinoma
BACKGROUND: Programmed cell death protein 1 (PD-1) is a key immune checkpoint that regulates peripheral tolerance and protects against autoimmunity. Programmed death ligand-2 (PD-L2) is a less studied ligand to PD-1 and has yet to be fully explored, especially in pancreatic ductal adenocarcinoma (PD...
Na minha lista:
| Foilsithe in: | J Immunother Cancer |
|---|---|
| Main Authors: | , , , , , , , , , |
| Formáid: | Artigo |
| Teanga: | Inglês |
| Foilsithe: |
BioMed Central
2019
|
| Ábhair: | |
| Rochtain Ar Líne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6716876/ https://ncbi.nlm.nih.gov/pubmed/31464648 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s40425-019-0703-0 |
| Clibeanna: |
Cuir Clib Leis
Gan Chlibeanna, Bí ar an gcéad duine leis an taifead seo a chlibeáil!
|